Equities

ASTRAZENECA 31

50UC:LSE

ASTRAZENECA 31

  • Price (GBP)109.13
  • Today's Change-0.05 / -0.05%
  • Shares traded-1.00
  • 1 Year change0.46%
  • Beta--
Data delayed at least 15 minutes.
More ▼

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
50UC:LSE since
announced
Transaction
value
Fusion Pharmaceuticals IncAnnounced19 Mar 202419 Mar 2024Announced-98.94%2.30bn
Amolyt Pharma SASAnnounced14 Mar 202414 Mar 2024Announced-98.96%1.05bn
Gracell Biotechnologies IncDeal completed26 Dec 202326 Dec 2023Deal completed-98.95%1.10bn
Icosavax IncDeal completed12 Dec 202312 Dec 2023Deal completed-98.92%862.87m
Data delayed at least 15 minutes.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.